Amylyx Pharmaceuticals, Inc. (AMLX) › Shareholders' EquityAmylyx Pharmaceuticals, Inc. (AMLX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2020: -$66.72M2021: -$151.17M2022: $340.61M2023: $433.43M2024: $164.76M2025: $305.26M$305.26M2020Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$305.26M+85.3%2024$164.76M-62.0%2023$433.43M+27.3%2022$340.61M+325.3%2021-$151.17M-126.6%2020-$66.72M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share